Stakeholder Views On The Acceptability Of Real-World Evidence For Informing Trial Design And Assessment Of Relative Effectiveness Of New Medicines
Abstract
Authors
P Jonsson M Czachorowski M Groves KR Abrams A Joyeux M Olson M Chambers S Garner